More about

Irritable Bowel Syndrome

News
February 10, 2020
4 min read
Save

Guest commentary: It’s time to deepen our understanding of abdominal pain in IBS

Guest commentary: It’s time to deepen our understanding of abdominal pain in IBS

In this guest commentary, Eric D. Shah, MD, MBA, director of the Gastrointestinal Motility Center at Dartmouth-Hitchcock Medical Center, discusses his recent study on abdominal pain in irritable bowel syndrome and argues that stratifying patients could evolve past bowel habits alone.

News
January 20, 2020
1 min read
Save

Abdominal pain differs between IBS subtypes

The presentation and characteristics of abdominal pain are not the same among the different subtypes of irritable bowel syndrome, according to study results.

News
January 16, 2020
6 min read
Save

Looking Back at 2019’s Top 10, Peer Tested by You

Looking Back at 2019’s Top 10, Peer Tested by You

As we enter the 6th year of Healio Gastroenterology and Liver Disease, it is worth looking back at what made us stand out in 2019: the Peer Tested content from online and print as it fared throughout the year.

News
January 15, 2020
2 min read
Save

One-in-four adults fit Rome IV criteria for functional bowel disorders

More than 25% of adults in the United States, Canada and United Kingdom fit the Rome IV criteria for at least one of the six functional bowel disorders, according to study results.

News
January 14, 2020
1 min read
Save

Ibsrela improves abdominal symptoms in IBS-C

Ibsrela improves abdominal symptoms in IBS-C

Ibsrela helped reduce abdominal symptoms, like bloating, cramping and fullness, in patients with constipation-predominant irritable bowel syndrome, according to study results.

News
December 05, 2019
2 min read
Save

7 recent reports on the gut microbiome

Healio Gastroenterology and Liver Disease presents the following reports on the most recent research and news on the gut microbiome.

News
December 05, 2019
1 min read
Save

Lactulose breath test predicts Xifaxan response in IBS-D

Patients with diarrhea-predominant irritable bowel syndrome who had a positive baseline result from a lactulose breath test were more likely to respond to Xifaxan therapy, according to results of open-label study.

News
November 21, 2019
1 min read
Save

Healio Disruptive Innovators at ACG 2019

Healio Gastroenterology and Liver Disease unveiled its second annual Disruptive Innovators Awards recipients at the American College of Gastroenterology Annual Scientific Meeting.

News
November 21, 2019
3 min read
Save

And Your 2019 Healio Disruptive Innovators Are ...

And Your 2019 Healio Disruptive Innovators Are ...

This award goes to a physician or institution that changed the face of the gastroenterology practice. The awardee is seen as an example of how patient care can be bettered through changes in administration, technique or the delivery of value-based care.

News
November 15, 2019
1 min read
Save

FDA hearing on fecal microbiota transplantation tops the week’s stories in gastroenterology

News about the FDA’s public comment session to hear testimony about their policy on fecal microbiota transplantation for patients with recurrent Clostridioides difficile infection was among the week’s top stories in gastroenterology.

View more